- Home
- TOVX vs NVVE Comparison
TOVX vs NVVE Comparison
Compare TOVX & NVVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TOVX | NVVE |
|---|---|---|
| Founded | 2001 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 8.2M |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | TOVX | NVVE |
|---|---|---|
| Price | $0.20 | $3.70 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 681.8K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,630,156.00 |
| Revenue This Year | N/A | $892.33 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.17 | $3.21 |
| 52 Week High | $2.08 | $200.80 |
Technical Indicators
Market Signals| Indicator | TOVX | NVVE |
|---|---|---|
| Relative Strength Index (RSI) | 38.79 | 83.64 |
| Support Level | $0.17 | $3.21 |
| Resistance Level | $0.24 | $4.08 |
| Average True Range (ATR) | 0.02 | 0.28 |
| MACD | -0.00 | 0.42 |
| Stochastic Oscillator | 24.56 | 75.61 |
Price Performance
Historical ComparisonAbout TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.